Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract

Overview of attention for article published in Clinical Epigenetics, December 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 1 X user
patent: 1 patent

f1000: 1 research highlight platform

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Patents Research highlights Dimensions citations

So far, Altmetric has seen 1 review on a research highlight platform.

Recommended in Faculty Opinions

25 Aug 2017

This research output was recommended by a member of Faculty Opinions.

This page shows the most recent research highlights that mention this research output.

Click here to find out how to access more activity.